RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 158 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.9%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STATE STREET CORP | 6,372,515 | $42,504,675 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 646,610 | $4,313 | 0.00% |
BlackRock Inc. | 10,631,857 | $70,914,487 | 0.00% |
VANGUARD GROUP INC | 10,933,584 | $72,927,005 | 0.00% |
New Millennium Group LLC | 275 | $1,834 | 0.00% |
Centiva Capital, LP | 13,618 | $90,832 | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 983,939 | $6,562,873 | 0.00% |
Russell Investments Group, Ltd. | 131,956 | $880,146 | 0.00% |
ExodusPoint Capital Management, LP | 31,137 | $208 | 0.00% |
NORTHERN TRUST CORP | 1,155,777 | $7,709,032 | 0.00% |
Skandinaviska Enskilda Banken AB (publ) | 48,200 | $321 | 0.00% |
RHUMBLINE ADVISERS | 209,878 | $1,400 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 2,743,484 | $18,299,045 | 0.00% |
Slow Capital, Inc. | 1,400 | $9,338 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 697,285 | $4,650,891 | 0.00% |
STRS OHIO | 62,100 | $414 | 0.00% |
DekaBank Deutsche Girozentrale | 60,000 | $387 | 0.00% |
SIGNATUREFD, LLC | 4,250 | $28,348 | 0.00% |
STATE OF WISCONSIN INVESTMENT BOARD | 50,311 | $335,574 | 0.00% |
Citadel Advisors | 605,515 | $4,038,785 | 0.00% |
External links
This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q1 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.